Stock Events

Stock Events

Kairos Pharma (KAPA) Q1 2025 Earnings

26FebConfirmed

Q1 1

Q4 2024

Q1 2025

-0.07

-0.05

-0.03

-0.02

Details

Expected EPS

-0.06

Actual EPS

-0.065

Surprise EPS

-0.01

Surprise Percent

+8.33%

Description

Kairos Pharma (KAPA) has reported earnings of -0.065 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.